jiliko casino app download
CHICAGO , Dec. 20, 2024 /PRNewswire/ -- In recognition of nearly 200,000 osteopathic physicians (DOs) and medical students in the U.S., more than 20 states and cities across the nation are observing December 2024 as Osteopathic Medicine Month. This designation recognizes the 150 th anniversary of osteopathic medicine, which applies a distinctive philosophy and approach to caring for patients in all areas of medicine, including primary care, surgery and specialty fields. DOs are fully licensed physicians who are trained to provide comprehensive care with a focus on preventive medicine and whole-person wellness. DOs hold some of the most distinguished positions in medicine today, caring for the U.S. President, overseeing the NASA medical team and leading some of the nation's top-ranked hospitals and health systems. The profession is one of the fastest-growing in health care, making up more than 10% of physicians and 28% of medical students in the U.S. Earlier this month, U.S. President Joe Biden issued a congratulatory letter to the New York Institute of Technology College of Osteopathic Medicine, recognizing the osteopathic profession's tremendous contributions to health care during the past 150 years. "As you celebrate this milestone anniversary, it is my hope that you are filled with pride in all the progress the osteopathic medical community has achieved—from pioneering medical discoveries to improving the health and well-being of Americans across the nation and so much more," the letter states. To date, more than 20 state and city leaders have issued proclamations declaring December 2024 as Osteopathic Medicine Month, including Alabama , Idaho , Illinois , Iowa , Michigan , Montana , Ohio , Oklahoma , Virginia , and West Virginia . "This remarkable achievement not only honors the rich history of our profession but also highlights the profound role of osteopathic medicine in health care today," said American Osteopathic Association President Teresa A. Hubka , DO, FACOOG (Dist). "Through patient-centered care and a commitment to understanding the root causes of illness, osteopathic physicians are shaping the future of medicine." For more information, visit www.osteopathic.org . About the AOA The American Osteopathic Association (AOA) represents more than 197,000 osteopathic physicians (DOs) and osteopathic medical students; promotes public health; encourages scientific research; serves as the primary certifying body for DOs; and is the accrediting agency for osteopathic medical schools. To learn more about DOs and the osteopathic philosophy of medicine, visit www.FindaDO.org . View original content to download multimedia: https://www.prnewswire.com/news-releases/more-than-20-states-and-cities-designate-december-as-osteopathic-medicine-month-302337665.html SOURCE American Osteopathic AssociationAirport Retailing Market Set to Soar with 15% CAGR, Projected to Reach USD 45 Billion by 2028
New details on a triple stabbing that occurred on Sunday night in Monterey County, California. Deputies with the Monterey County Sheriff's Office responded to an area for reports of a stabbing. Deputies then located three people with stab wounds. Their injuries ranged from minor to critical. They were taken to a local hospital and are expected to survive. Deputies said that Devin Wolfgang Vandorhoef, 25, of Canada, became obsessed with a woman he played video games online with for years. He boarded a plane with Darius Avery Whyte, 25, of Canada, to Salinas, California. Vandorhoef did not tell the woman he played video games with online that he was in town with his friend. Vandorhoff then posed as a delivery man while carrying a package that contained handcuffs, knives and duct tape, per a deputy spokesperson. A deputy spokesperson is unsure how the suspect intended to use these items. When Vanderhoef knocked at the woman's door, her boyfriend answered the door. Vanderhoef then began stabbing the woman's boyfriend, who suffered critical injuries but is expected to survive. The woman then came to her boyfriend's defense and stabbed Vanderhoff with a sharp metal object, said the spokesperson. Vanderhoef then strangled and stabbed the woman, causing moderate injuries. Vandorhoef suffered various critical stab wounds during the struggle. Whyte was questioned at the scene but said he did not know what was going on and was allowed to leave. However, further investigation revealed he was a part of the scheme and was arrested Monday morning at a tarmac in San Jose as he was preparing to fly back to Canada. Vandorhoef and Whyte were both booked into Monterey County Jail. Vandorhoef was booked for attempted murder, conspiracy to commit a crime, mayhem, stalking and burglary. His bail was set at $4.15 million. Whyte was booked for conspiracy to commit a crime and attempted murder. His bail was set at $1 million.Game-changing holiday gifts for building fires, printing photos, watching birds and moreWASHINGTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the "Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today issued the following statement in response to a short seller report published on November 26, 2024 by Fuzzy Panda Research ("Fuzzy Panda”). Fuzzy Panda is a self-proclaimed short seller who stands to realize significant gains if the price of ASP Isotopes's stock declines. Based upon ASP Isotopes's and its legal counsel's preliminary review and evaluation of the report, the Company believes the report includes speculative conjecture and claims that are inaccurate or filled with innuendo in an attempt to mislead investors about ASP Isotopes's technology, leadership and future growth. Investors are encouraged to review the Company's public filings made with the SEC. ASP Isotopes is in the process of commissioning three isotope enrichment facilities in South Africa and has hosted commercial partners and investors at these facilities. The first facility is scheduled to enrich Carbon-14 for use in healthcare and agrochemicals. The second facility is scheduled to enrich Silicon-28, which the Company believes will enable faster, more efficient semiconductors for use in artificial intelligence and quantum computing. The third facility is scheduled to enrich Ytterbium-176, a critically important raw material used in the production of radio-oncology therapies. ASP Isotopes values transparency and open communication. Canaccord Genuity's analyst, George Gianarikas, will host a fire side chat with ASP Isotopes's Chairman and Chief Executive Officer, Paul Mann, at 10am EST on November 27, 2024. Please contact your Canaccord Genuity sales representative for dial in details. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process ("ASP technology”). The Company's initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28 for enabling quantum computing; Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, Lithium-7 and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit www.aspisotopes.com . Forward Looking Statements This press release contains "forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the future of the Company's enrichment technologies, the market demand for enriched isotopes, and the commencement of supply of enriched isotopes to customers. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as "believes,” "plans,” "anticipates,” "expects,” "estimates,” "projects,” "will,” "may,” "might,” and words of a similar nature. Examples of forward-looking statements include, among others but are not limited to, statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the construction and commissioning of our enrichment plants or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions; contracts, dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; and the competitive nature of our industry. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. This press release includes market and industry data and forecasts that we obtained from internal research, publicly available information and industry publications and surveys. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Unless otherwise noted, statements as to our potential market position relative to other companies are approximated and based on third-party data and internal analysis and estimates as of the date of this press release. We have not independently verified this information, and it could prove inaccurate. Industry and market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data-gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the information and forecasts from sources cited herein. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad- Investor relations Email: [email protected] Telephone: 561-709-3043
ROANOKE, Va., Dec. 20, 2024 /PRNewswire/ -- Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®") today announced that it will release its fourth quarter and fiscal year 2024 results on Monday, December 23, 2024. The fourth quarter and full year results are for the three-month and twelve-month periods ended October 31, 2024. The Company will also host a conference call on Monday, December 23, 2024, at 10:30 a.m. Eastern Time. Individuals wishing to participate in the conference call should call (800) 445-7795 in the U.S. or (785) 424-1699 internationally, Conference ID: OCCQ424. For interested individuals unable to join the call, a replay will be available through Monday, December 30, 2024, by dialing (800) 839-7414 or (402) 220-6068. The call will also be broadcast live over the internet and can be accessed by visiting the investor relations section of the Company's website at . As in the past, OCC will answer questions from analysts and fund investors during the conference call. OCC also invites individual investors to submit questions in advance of the conference call. Questions should be submitted in writing to [email protected] by 9:00 a.m. Eastern Time on Monday, December 23, 2024. Company Information Optical Cable Corporation ("OCC®") is a leading manufacturer of a broad range of fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment and specialty markets (collectively, the non-carrier markets) and also the wireless carrier market, offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. OCC® is internationally recognized for pioneering innovative fiber optic and copper communications technologies, including fiber optic cable designs for the most demanding environments and applications, copper connectivity designs to meet the highest data communication industry standards, as well as a broad product offering built on the evolution of these fundamental technologies. OCC uses its expertise to deliver cabling and connectivity products and integrated solutions that are best suited to the performance requirements of each end-user's application. And OCC's solutions offerings cover a broad range of applications-from commercial, enterprise network, datacenter, residential and campus installations to customized products for specialty applications and harsh environments, including military, industrial, mining, petrochemical and broadcast applications, as well as for the wireless carrier market. Founded in 1983, OCC is headquartered in Roanoke, Virginia with offices, manufacturing and warehouse facilities located in Roanoke, Virginia, near Asheville, North Carolina and near Dallas, Texas. OCC's facilities are ISO 9001:2015 registered and its Roanoke and Dallas facilities are MIL-STD-790G certified. Optical Cable CorporationTM, OCC®, Procyon®, Superior Modular ProductsTM, SMP Data CommunicationsTM, Applied Optical SystemsTM, and associated logos are trademarks of Optical Cable Corporation. Further information about OCC® is available at . AT THE COMPANY: Neil Wilkin Tracy Smith Chairman, President & CEO Senior Vice President & CFO (540) 265-0690 (540) 265-0690 [email protected] [email protected] AT JOELE FRANK, WILKINSON BRIMMER KATCHER: Aaron Palash Spencer Hoffman (212) 355-4449 ext. 8603 (212) 355-4449 ext. 8928 [email protected] [email protected] SOURCE Optical Cable Corporation MENAFN20122024003732001241ID1109018536 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Lisa Kudrow dishes on reason why ‘Friends’ is still popular Lisa Kudrow has a theory for why young fans still love ‘Friends’ Lisa Kudrow thinks there is a particular reason why Friends remains one of the most popular shows even among younger generations today. The 61-year-old actress shared that she isn’t surprised to see fans attached to the 90s sitcom in an interview and explained why. “I’m not amazed because it’s good and it’s familiar,” Kudrow, who played the fan-favourite character of Phoebe Buffay told Page Six , on Friday, December 7th. The Come Back star continued to explain that she believes Friends holds a “subconscious nostalgia” for younger fans who grew up with cell phones and social media. “For something they don’t have, which is in-person connections and relations. And that’s always been at the heart of every successful show.” She added, “That’s why people get attached to them and then if it’s funny, there [are] good performances, good jokes, that’s a bonus and Friends had all that.” The Emmy winning artist shared that many people around her questioned if the sitcom would ever succeed and asked her if “a bunch of young people sitting on a couch talking” was even a show. “That’s not my problem,” Kudrow quipped. “I’m just in it, but yes it was a show.” The final episode of fan's beloved show, which aired in May 2004, had over 52 million viewers, making it the fifth most-watched series finale in US history. The Friends alum is set to appear on the screen with her upcoming movie No Good Deed which comes out on December 12th. Gigi Hadid stuns onlookers with cosy appearance in NYC Princess Charlene rocks flared jeans for family day out Angelina Jolie struts in Paris set photos, despite broken toe Zachary Levi prepares to welcome first child with Maggie Keating‘Is my customer human?’ Banks must rely on AI to uncover automated fraud